🔥 Tuesday 10 March 2026 Tue, 10 Mar 2026

Lithium Energy Limited has reported promising initial assay results from its latest drilling program at the Burke-Mt Dromedary graphite deposits, revealing substantial high-grade graphite mineralisation that could expand and unify its resource base.

Lynas Rare Earths and Japan Australia Rare Earths B.V. have extended their supply agreement to 2038, securing firm commitments for critical rare earths with a pricing floor and upside sharing mechanism.

Elanor Investors Group reported a $57 million statutory loss for FY25 but is progressing a $125 million recapitalisation with Rockworth Capital Partners to stabilise its balance sheet amid ongoing financial challenges.

Winton Land Limited has secured conditional approval under the Fast-track Approvals Act 2024 for its Sunfield masterplanned community, paving the way for thousands of homes and extensive commercial precincts.

The Supreme Court of New South Wales has approved the convening of meetings for National Storage REIT securityholders to vote on a $2.86 per security acquisition offer by a Brookfield-GIC consortium. The independent expert report supports the transaction as fair and reasonable, with the NSR Board unanimously recommending approval.

Adherium Limited reports a strong uptick in Remote Patient Monitoring revenue and device activations, driven by new reimbursement codes and strategic partnerships, aiming for 10,000 RPM patients by year-end.

IRIS Metals has secured a farm-in agreement to earn up to 100% ownership of the Finley Basin Tungsten Project in Montana, marking a strategic expansion into a critical mineral vital for defence and advanced manufacturing.

Imugene Limited reports striking early results from its Phase 1b azer-cel trial, achieving a 100% overall response rate in chronic lymphocytic leukemia and 80% in marginal zone lymphoma, while broadening its study to include a BTK inhibitor combination.

QPM Energy Limited has announced a substantial upgrade to its Moranbah Gas Project reserves and resources, now certified at over 1,000 petajoules, positioning the company as a key player in Queensland’s evolving gas and electricity markets.

Victory Metals Limited has reported a record-breaking rare earth oxide intersection of 11,565 ppm TREO at its North Stanmore project, reinforcing its status as a world-class heavy rare earth deposit. The December 2025 drilling program also advances resource confidence and metallurgical prospects, positioning the project as a key Western supplier of critical rare earths.

American Tungsten & Antimony Ltd has reported a significant high-grade antimony discovery from its maiden drilling at the Antimony Canyon Project in Utah, confirming a large-scale mineralised system with promising grades and thicknesses.

Chariot Resources has secured Nigerian government approval for the transfer of six lithium licenses, marking a key step toward acquiring a majority stake in a promising Nigerian lithium portfolio. This regulatory milestone enables immediate exploration and mining activities at multiple projects amid soaring lithium prices.

OzAurum Resources has secured environmental approval for Stage 1 of its Mulgabbie North Gold Project, clearing a major regulatory hurdle and accelerating its path to near-term production.

Hammer Metals is set to accelerate exploration with a 3,000m drilling campaign at its Kalman Critical Metals Deposit and other key copper-gold prospects in Mount Isa, aiming to upgrade resources and underpin a maiden Scoping Study.

Western Gold Resources has locked in critical approvals and agreements to accelerate production at its Gold Duke Project in Western Australia, backed by an updated resource estimate and a binding toll milling contract.

Kingsland Minerals reports outstanding graphite assay results from its Leliyn project, advancing metallurgical testing with Quinbrook to assess battery anode material potential.

Dimerix Limited has completed dosing of the last adult patient in its ACTION3 Phase 3 trial for DMX-200, exceeding its recruitment target and setting the stage for key regulatory milestones.

Tetratherix Limited has raised approximately $5 million to fast-track its Tutelix prostate spacer into pivotal clinical trials across Australia and the US, aiming to improve radiation therapy for prostate cancer patients.

Metal Bank reports exceptional gold recovery results from its Seven Leaders Prospect near Kalgoorlie, highlighting a 72.5% gravity recovery and over 99% leaching efficiency, underpinning its near-term production ambitions.

Orica reports solid first-half earnings growth led by digital and specialty chemicals, while launching a $100 million cost reduction program to navigate supply disruptions and litigation headwinds.

Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ nerve repair product in the UK, positioning itself for a rapid commercial launch pending regulatory approval.

Matsa Resources has reported a strong finish to Campaign 2 at its Devon Pit Gold Mine, doubling gold production and generating nearly $29 million in sales. Campaign 3 mining is now underway, signalling continued momentum.

Clarity Pharmaceuticals has completed enrolment in its Phase III AMPLIFY trial for the Cu-SAR-bisPSMA imaging agent, advancing its bid for FDA approval in prostate cancer diagnostics.

Mammoth Minerals has secured an exclusive option to acquire the historic Imperial Gold Mine near its Excelsior Springs project in Nevada, significantly expanding its landholding and exploration potential in a prolific gold district.